InvestorsHub Logo
Post# of 251715
Next 10
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

Re: None

Monday, 03/31/2014 9:09:30 AM

Monday, March 31, 2014 9:09:30 AM

Post# of 251715
FDA confirms lifting of clinical hold on Oxygen Bio's Oxycyte
Oxygen Biotherapeutics (OXBT) has received written confirmation that the FDA has lifted a hold on the clinical trials of the company's Oxycyte treatment for traumatic brain injury.
The FDA had informed Oxygen Bio of its decision verbally earlier this month.
Oxygen has been enrolling patients in Israel for a Phase IIb study to evaluate the safety and tolerability of Oxycyte in patients with severe non-penetrating traumatic brain injury.
Shares jump 10.6% premarket
http://seekingalpha.com/pr/9414453-oxygen-biotherapeutics-inc-provides-an-update-on-communication-with-the-fda-regarding-oxycyte-development-program

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.